最近在克服癌症免疫疗法基于细胞的传递系统障碍方面的进展
Yingyue Ding1,2,3, Yixin Wang1,2,3, Quanyin Hu1,2,3
1Pharmaceutical Sciences Division School of Pharmacy University of Wisconsin-Madison Madison Wisconsin USA.
Exploration (Beijing, China)
|June 16, 2023
概括
基于细胞的输送系统通过有效向瘤提供了有前途的癌症免疫疗法. 然而,克服生物障碍对于提高治疗疗效和减少副作用至关重要.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 基于细胞的输送系统正在获得癌症免疫治疗的吸引力,因为它们的生物相容性和瘤向能力.
- 存在各种设计策略,包括细胞表面修饰,膜涂层,封装,基因工程和外体细胞利用.
研究的目的:
- 为癌症免疫治疗提供基于细胞的传递系统设计原则的概述.
- 识别阻碍基于细胞的免疫疗法的疗效的解剖学,代谢和免疫学障碍.
- 总结开发的新策略来克服这些障碍.
主要方法:
- 关于癌症免疫治疗中基于细胞的输送系统的当前文献的综述.
- 分析设计原则及其对治疗结果的影响.
- 识别和分类生理和免疫挑战.
- 汇编应对这些挑战的新兴战略.
主要成果:
- 基于细胞的免疫疗法具有显著的潜力,可以提高疗效并减少不良影响.
- 关键的限制包括物理障碍,免疫抑制瘤微环境和代谢限制.
- 新的交付策略正在出现,以克服这些障碍.
结论:
- 基于细胞的传递系统的进步对于最大限度地发挥癌症免疫疗法的潜力至关重要.
- 解决生物学和免疫学障碍对于临床翻译至关重要.
- 未来的研究应该专注于克服下一代基于细胞的免疫疗法所面临的障碍.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
673
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
888
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Cancer Vaccines
434
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
434
Microorganisms in Medicine and Therapeutics
72
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
72
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Hybridoma Technology
15.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.0K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
